Why Evofem Biosciences Is Trading Higher Today

Evofem Biosciences Inc EVFM shares are trading higher on Monday after Piper Sandler initiated coverage on the company's stock with an Outperform rating and announced an $11 price target.

Evofem Biosciences provides woman-controlled protection from sexually transmitted infections. It addresses women's unmet medical needs through the discovery, development and commercialization of healthcare products.

Evofem products that are in development phase include Amphora primarily for the prevention of pregnancy and prevention of ur

Evofem Biosciences shares were trading up 6.19% at $3.52 on Monday. The stock has a 52-week high of $7.50 and a 52-week low of $3.20.